Back to the articles list | Back to browse issues page

XML Print

Comparison of clinical biochemistry indices between type 2 diabetic patients with nephropathy and non-nephropathy in Gorgan
Alaa Kazem1 , Azad Reza Mansurian1 , Golam Reza Vaghari1 , Seyed Mostafa Mir1 , Fatemeh Mohammadzadeh2
1- Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran
2- Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran , msoheila66@yahoo.com
Abstract:   (940 Views)
Background: Diabetic nephropathy is a major cause of kidney failure. The current study aimed to measure serum and urine albumin as well as other biochemical markers in individuals with type 2 diabetic nephropathy and to identify quick diagnostic approaches in these patients. 
Method: The case-control study consisted of 40 patients with diabetic nephropathy and 40 diabetic patients without nephropathy. After assessing the biochemichal and clinical parameters, based on the ratio of random urine albumin to creatinine, patients were separated into two groups: patients with or without albuminuria. SPSS v18 software was used to analyze the results.
Results: In diabetic patients, the levels of urea, creatinine, uric acid were significantly higher in comparison to the control group and were 64.68±46.84, 2.01±1.82, 5.35±2.23 respectively. The average content of serum albumin in diabetic patients with nephropathy was notably lower compared to non-nephropathy patients (3.74±0.88. and 4.35±0.28) (p < 0.05). In diabetic nephropathy patients, urinary albumin had a direct relationship with serum creatinine level (r=0.347, p=0.028). In the control group, it was possible to check the status of serum albumin by measuring the level of creatinine (r = -0.305, p = 0.056), urea (r = -0.333, p = 0.036) and HbA1C (r = -0.376, p = 0.017).
Conclusion: The results revealed that high level of urinary albumin in patients with diabetic nephropathy has a direct association with the serum creatinine level, indicating a helpful index in the evaluation of nephropathy patients with albuminuria. However, further studies with a larger number of participants is required.
 
Keywords: Type 2 diabetes, Nephropathy patients, Non-nephropathy patients, Biochemical indicators
Full-Text [PDF 424 kb]   (202 Downloads)    
Research Article: Research Article | Subject: Biochemistry
Received: 2023/02/4 | Accepted: 2024/07/23
References
1. Bellary S, Paul O'Hare J, Raymond NT, Mughal S, Hanif WM, Jones A, et al. Premature cardiovascular events and mortality in south Asians with type 2 diabetes in the United Kingdom Asian diabetes study-effect of ethnicity on risk. Curr Med Res Opin. 2010;26(8):1873-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Arambewela MH, Somasundaram NP, Jayasekara HBPR, Kumbukage MP, Jayasena PMS, Chandrasekara CMPH, et al. Prevalence of chronic complications, their risk factors, and the cardiovascular risk factors among patients with type 2 diabetes attending the diabetic clinic at a Tertiary Care Hospital in Sri Lanka. J Diabetes Res. 2018:2018:4504287. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. McFarlane P, Cherney D, Gilbert RE, Senior P. Chronic kidney disease in diabetes. Can J Diabetes. 2018;42:S201-S9. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. Mok KY, Chan PF, Lai LK, Chow KL, Chao DV. Prevalence of diabetic nephropathy among Chinese patients with type 2 diabetes mellitus and different categories of their estimated glomerular filtration rate based on the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation in primary care in Hong Kong: a cross-sectional study. J Diabetes Metab Disord. 2019;18(2):281-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Dedov II, Shestakova MV, Vikulova OK. Epidemiology of diabetes mellitus in Russian Federation: clinical and statistical report according to the federal diabetes registry. Diabetes mellitus. 2017;20(1):13-41. [View at Publisher] [DOI] [Google Scholar]
6. Kawai Y, Masutani K, Torisu K, Katafuchi R, Tanaka S, Tsuchimoto A, et al. Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy: A possible role of albumin as an antioxidant agent. PloS one. 2018;13(5):e0196655. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Yokoyama H, Araki S-i, Kawai K, Yamazaki K, Tomonaga O, Shirabe S-i, et al. Declining trends of diabetic nephropathy, retinopathy and neuropathy with improving diabetes care indicators in Japanese patients with type 2 and type 1 diabetes (JDDM 46). BMJ Open Diabetes Res Care. 2018;6(1):e000521. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Dabla PK. Renal function in diabetic nephropathy. World J Diabetes. 2010;1(2):48-56. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Viswanathan V, Snehalatha C, Kumutha R, Jayaraman M, Ramachandran A. Serum albumin levels in different stages of type 2 diabetic nephropathy patients. Indian J Nephrol. 2004;14(3):89-92. [View at Publisher] [DOI] [Google Scholar]
10. Haffner SM, Morales PA, Gruber MK, Hazuda HP, Stern MP. Cardiovascular risk factors in non-insulin-dependent diabetic subjects with microalbuminuria. Arterioscler Thromb. 1993;13(2):205-10. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Sheng C-S, Hu B-C, Fan W-X, Zou J, Li Y, Wang J-G. Microalbuminuria in relation to the metabolic syndrome and its components in a Chinese population. Diabetol Metab Syndr. 2011;3(1):6. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Lai Y-R, Chiu W-C, Huang C-C, Tsai N-W, Wang H-C, Lin W-C, et al. HbA1C variability is strongly associated with the severity of peripheral neuropathy in patients with type 2 diabetes. Front Neurosci. 2019;13:90. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. Chiu W-C, Lai Y-R, Cheng B-C, Huang C-C, Chen J-F, Lu C-H. HbA1C variability is strongly associated with development of macroalbuminuria in normal or microalbuminuria in patients with type 2 diabetes mellitus: a six-year follow-up study. Biomed Res Int. 2020:2020:7462158. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Zhang J, Zhang R, Wang Y, Li H, Han Q, Wu Y, et al. The level of serum albumin is associated with renal prognosis in patients with diabetic nephropathy. J Diabetes Res. 2019:2019:7825804. [View at Publisher] [DOI] [PMID] [Google Scholar]
15. Zhang J, Zhang R, Wang Y, Li H, Han Q, Wu Y, et al. The level of serum albumin is associated with renal prognosis in patients with diabetic nephropathy. J Diabetes Res.2019:2019:7825804 [View at Publisher] [DOI] [PMID] [Google Scholar]
16. AbuMustafa AM. clinical and Biochemical associations with Diabetic retinopathy in Male Patients in the gaza strip. Front Endocrinol (Lausanne). 2017:8:302. [View at Publisher] [DOI] [PMID] [Google Scholar]
17. Kocak MZ, Aktas G, Duman TT, Atak BM, Savli H. Is Uric Acid elevation a random finding or a causative agent of diabetic nephropathy? Rev Assoc Med Bras (1992). 2019;65(9):1155-60. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Latif H, Iqbal A, Rathore R, Butt NF. Correlation between serum uric acid level and microalbuminuria in type-2 diabetic nephropathy. Pak J Med Sci. 2017;33(6):1371-5. [View at Publisher] [DOI] [PMID] [Google Scholar]
19. Behradmanesh S, Horestani MK, Baradaran A, Nasri H. Association of serum uric acid with proteinuria in type 2 diabetic patients. J Res Med Sci. 2013;18(1):44-6. [View at Publisher] [PMID] [Google Scholar]
20. Warjukar P, Jain P, Kute P, Anjankar A, Ghangale S. Study of microalbuminuria and uric acid in type 2 diabetes mellitus. Int J Cur Res Rev. 2020;2020. [View at Publisher] [DOI] [Google Scholar]
21. Khan MI, Usman K, Ashfaq F, Himanshu D, Ali W, Idris M. Association of Hs-CRP and HbA1C with Microalbuminuria in Type-2 Diabetic patients in North India. Biomedical Research. 2012;23(3):380-4. [View at Publisher] [Google Scholar]
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.